Financial Health Report: Protara Therapeutics Inc (TARA)’s Ratios Tell a Tale

Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.

Protara Therapeutics Inc (NASDAQ: TARA) closed the day trading at $3.00 up 0.67% from the previous closing price of $2.98. In other words, the price has increased by $0.67 from its previous closing price. On the day, 0.92 million shares were traded. TARA stock price reached its highest trading level at $3.3399 during the session, while it also had its lowest trading level at $2.87.

Ratios:

For a better understanding of TARA, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 10.53 and its Current Ratio is at 10.53. In the meantime, Its Debt-to-Equity ratio is 0.09 whereas as Long-Term Debt/Eq ratio is at 0.07.

On June 04, 2021, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $40.

On February 17, 2021, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $43.Oppenheimer initiated its Outperform rating on February 17, 2021, with a $43 target price.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 10 ’24 when Opaleye Management Inc. sold 151,700 shares for $3.11 per share. The transaction valued at 472,424 led to the insider holds 2,380,294 shares of the business.

Opaleye Management Inc. sold 30,600 shares of TARA for $94,526 on May 09 ’24. The 10% Owner now owns 2,531,994 shares after completing the transaction at $3.09 per share.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TARA now has a Market Capitalization of 61770000 and an Enterprise Value of 11773928.

Stock Price History:

The Beta on a monthly basis for TARA is 1.86, which has changed by -0.10979229 over the last 52 weeks, in comparison to a change of 0.26265144 over the same period for the S&P500. Over the past 52 weeks, TARA has reached a high of $5.24, while it has fallen to a 52-week low of $1.04. The 50-Day Moving Average of the stock is -13.79%, while the 200-Day Moving Average is calculated to be 24.24%.

Shares Statistics:

Over the past 3-months, TARA traded about 301.35K shares per day on average, while over the past 10 days, TARA traded about 378560 shares per day. A total of 20.59M shares are outstanding, with a floating share count of 16.50M. Insiders hold about 19.88% of the company’s shares, while institutions hold 38.43% stake in the company. Shares short for TARA as of 1714435200 were 1030785 with a Short Ratio of 3.42, compared to 1711584000 on 65228. Therefore, it implies a Short% of Shares Outstanding of 1030785 and a Short% of Float of 6.6599995.

Earnings Estimates

Protara Therapeutics Inc (TARA) is presently subject to a detailed evaluation by 3.0 analysts, each offering their unique perspectives on its market standing.On average, analysts expect EPS of -$0.8 for the current quarter, with a high estimate of -$0.44 and a low estimate of -$1.09, while EPS last year was -$1. The consensus estimate for the next quarter is -$0.82, with high estimates of -$0.44 and low estimates of -$1.14.

Analysts are recommending an EPS of between -$2.0 and -$5.35 for the fiscal current year, implying an average EPS of -$3.86. EPS for the following year is -$4.14, with 4.0 analysts recommending between -$1.81 and -$5.95.

Most Popular

[the_ad id="945"]